or
forgot password

    • cancer clinical trials in lafayette, IN

    • Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Extensive Stage Small Cell Lung Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904
    Non Small Cell Lung Carcinoma
    The Plenaxis® Experience Study
    Unity HealthCare DBA Lafayette Clinic of Urology
    Lafayette, Indiana 47905
    Prostate Cancer
    Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma
    Horizon Oncolgy Center
    Lafayette, Indiana
    Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade
    PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Breast Cancer
    Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Multiple Myeloma
    Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Small Cell Lung Cancer
    A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Breast Cancer
    Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Lung Cancer
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Clarian Arnett Cancer Care
    Lafayette, Indiana 47904
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    A Biological Sample Collection Protocol of Women With and Without Breast Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Breast Cancer
    Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Ovarian Cancer
    Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Breast Cancer
    A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Metastatic Breast Cancer
    Sutent + Taxol for Advanced Esophageal Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Esophageal Cancer
    Lonafarnib in Metastatic Breast Cancer
    Arnett Cancer Care

    Trial Locations
    Arnett Cancer Care
    Horizon Oncology Center
    Metastatic Breast Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    IU Health Arnett
    Lafayette, Indiana
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Advanced Gastric Cancer, Gastro-esophageal Junction Cancer
    A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
    Investigational Site
    Lafayette, Indiana 47905
    Metastatic Breast Cancer
    A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Lymphoma, Non-Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma, Leukemia, Lymphocytic
    Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
    Arnett Cancer Care
    Lafayette, Indiana 47904
    Lymphoma, Non-Hodgkin
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Horizon Oncology Center
    Lafayette, Indiana 47905
    Locally Recurrent or Metastatic Breast Cancer